Although CDH23‐associated NSHL has traditionally been associated with congenital onset and profound severity, recent studies have revealed a broad phenotypic spectrum that includes individuals with biallelic variants presenting HL in the second to seventh decade of life, expanding the understanding of DFNB12.73 This evidence concerns the gene CDH23 and Hodgkins lymphoma.